- So-Young International press release (NASDAQ:SY): Q4 EPADS OF $0.03
- Total revenues were RMB390.6 million (US$55.0 million), compared with RMB325.1 million in the corresponding period of 2022, in line with previous guidance.
- Information services and other revenues were RMB268.1 million (US$37.8 million), an increase of 15.8% from RMB231.5 million in the same period of 2022. The increase was primarily due to an increase in revenues generated by So-Young Prime.
- Reservation services revenues were RMB20.6 million (US$2.9 million), a decrease of 20.7% from RMB26.0 million in the same period of 2022. The decrease was primarily due to the operating strategy which gave higher subsidies to end users.
- Sales of medical products and maintenance services revenues were RMB101.9 million (US$14.4 million), an increase of 50.6% from RMB67.7 million in the same period of 2022, primarily due to an increase in sales of cosmetic injectables.
- Average mobile MAUs were 2.7 million, compared with 4.0 million in the fourth quarter of 2022.
- Number of medical service providers subscribing to information services on So-Young's platform was 1,289, compared with 1,489 in the fourth quarter of 2022.
- Total number of purchasing users through reservation services was 139.0 thousand and the aggregate value of medical aesthetic treatment transactions facilitated by So-Young's platform was RMB470.9 million.